BIOFRONTERA INC. WARRANTS

NASDAQ: BFRIW (Biofrontera Inc. Warrants)

Last update: 5 days ago, 12:10AM

0.020

0.00 (-13.04%)

Previous Close 0.023
Open 0.023
Volume 67,603
52 Weeks Range
0.020 (0%) — 0.025 (25%)
Profit Margin -38.34%
Operating Margin (TTM) -64.69%
Diluted EPS (TTM) -1.30
Quarterly Revenue Growth (YOY) 34.00%
Total Debt/Equity (MRQ) 13.20%
Current Ratio (MRQ) 1.88
Operating Cash Flow (TTM) -18.91 M
Levered Free Cash Flow (TTM) -17.96 M
Return on Assets (TTM) -40.24%
Return on Equity (TTM) -149.41%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Mixed Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Biofrontera Inc. Warrants - -

Stockmoo Score

0.0
Analyst Consensus 0.0
Insider Activity NA
Price Volatility NA
Technical Moving Averages 0.0
Technical Oscillators 0.0
Average 0.00

Similar Stocks

Stock Market Cap DY P/E P/B
BFRIW - - - -
CTOR 100 M - - 3.32
SHPH 4 M - - 3.06
ACORQ 186 K - - -
NEPTF 87 K - - 0.560
ALVOW - - - -

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug for use in combination with the BF-RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also provides Xepi, a topical non-fluorinated quinolone that inhibits bacterial growth for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria